NCT04318379View on ClinicalTrials.gov

Therapeutic Hepatitis C Virus Vaccine

PHASE1UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 20, 2021

Primary Completion Date

February 28, 2023

Study Completion Date

December 31, 2023

Conditions
Chronic Hepatitis C Infection
Interventions
BIOLOGICAL

HCVax

HCVax is a lentiviral vector encoding several HCV antigens

Trial Locations (1)

23298

RECRUITING

Virginia Commonwealth University, Medical Center, Richmond

Sponsors
All Listed Sponsors
lead

GeneCure Biotechnologies

INDUSTRY